Information Letter on Dantrolene 20 mg powder for solution for injection (DANTRIUM IV): use filtration device provided with product to reduce risk of injection site reactions
2019.03.01
Active substance: Dantrolen
The company Norgine informs in coordination with the Federal Institute for Drugs and Medical Devices (BfArM) on a new filtration device (BBraun Mini-Spike) to reduce the risk of reactions at the injection site.
Products still on the market must continue to be used together with the existing blunt filter needle.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN